Gut Microbiota Modifications and Weight Regain in Morbidly Obese Women After Roux-en-Y Gastric Bypass
- PMID: 32915360
- DOI: 10.1007/s11695-020-04956-9
Gut Microbiota Modifications and Weight Regain in Morbidly Obese Women After Roux-en-Y Gastric Bypass
Abstract
Introduction: The relationship between late post-bariatric surgery weight regain and gut microbiota is not completely understood.
Objective: To analyze the profile of gut microbiota among patients with and without late weight regain after post-Roux-en-Y gastric bypass (RYGB) and to compare it with a control group (CG) comprised of obese Brazilian individuals.
Methods: This is a cross-sectional study which enrolled 34 morbidly obese women divided into 3 groups: post-Roux-en-Y gastric bypass without (RYGB_non-regain), and with weight regain (RYGB_regain) at least 5 years after surgery, and a CG of preoperative individuals. Gut microbiota was determined by metagenomic analyses.
Results: The alpha diversity was higher in groups RYGB non-regain and RYGB regain when compared with CG (p < 0.05). Both RYGB non-regain and RYGB regain groups showed a lower abundance of the phylum Bacteroidetes when compared with CG (p < 0.01). The genera Bacteroides and SMB53 were increased in CG (p < 0.05). Group RYGB non-regain showed more abundance of the Akkermansia genus when compared with CG and group RYGB regain (p < 0.05). RYGB non-regain showed a greater abundance of the Phascolarctobacterium genus and lower of the SMB53 genus when compared with CG (p < 0.05). RYGB non-regain showed a greater abundance of the Phascolarctobacterium genus and a lower of the SMB53 genus when compared with CG (p < 0.05).
Conclusion: The gut microbiota of individuals which presented late weight regain after RYGB was significantly different in comparison to individuals with a successful weight loss, a finding that points towards a significant role of gut microbiota on weight loss and maintenance after surgery.
Keywords: Bariatric surgery; Gastric bypass; Microbiota; Obesity; Weight loss.
Similar articles
-
The Role of the Gut Microbiota in Sustained Weight Loss Following Roux-en-Y Gastric Bypass Surgery.Obes Surg. 2019 Apr;29(4):1259-1267. doi: 10.1007/s11695-018-03653-y. Obes Surg. 2019. PMID: 30604078
-
Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota.Genome Med. 2016 Jun 15;8(1):67. doi: 10.1186/s13073-016-0312-1. Genome Med. 2016. PMID: 27306058 Free PMC article. Clinical Trial.
-
Alterations of Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Sprague-Dawley Rats.Obes Surg. 2017 Feb;27(2):295-302. doi: 10.1007/s11695-016-2297-7. Obes Surg. 2017. PMID: 27440168
-
Effects of gastric bypass bariatric surgery on gut microbiota in patients with morbid obesity.Gut Microbes. 2024 Jan-Dec;16(1):2427312. doi: 10.1080/19490976.2024.2427312. Epub 2024 Nov 17. Gut Microbes. 2024. PMID: 39551972 Free PMC article. Review.
-
Weight Regain Following Roux-en-Y Gastric Bypass: Etiology and Surgical Treatment.Isr Med Assoc J. 2019 Dec;21(12):823-828. Isr Med Assoc J. 2019. PMID: 31814347 Review.
Cited by
-
Artificial Intelligence in Bariatric Surgery: Current Status and Future Perspectives.Obes Surg. 2022 Aug;32(8):2772-2783. doi: 10.1007/s11695-022-06146-1. Epub 2022 Jun 17. Obes Surg. 2022. PMID: 35713855 Free PMC article.
-
The impact of Hafnia alvei HA4597™ on weight loss and glycaemic control after bariatric surgery - study protocol for a triple-blinded, blocked randomized, 12-month, parallel-group, placebo-controlled clinical trial.Trials. 2023 May 29;24(1):362. doi: 10.1186/s13063-023-07383-0. Trials. 2023. PMID: 37248499 Free PMC article.
-
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review.Metabolites. 2021 May 31;11(6):353. doi: 10.3390/metabo11060353. Metabolites. 2021. PMID: 34072995 Free PMC article. Review.
-
Impact of a very low-calorie ketogenic diet on metabolic and microbiota outcomes in post-bariatric patients and bariatric-Naïve individuals: A comparative pilot study.Diabetes Obes Metab. 2025 Apr;27(4):1950-1959. doi: 10.1111/dom.16187. Epub 2025 Jan 10. Diabetes Obes Metab. 2025. PMID: 39791264 Free PMC article.
-
Reversal of Functional Brain Activity Related to Gut Microbiome and Hormones After VSG Surgery in Patients With Obesity.J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3619-e3633. doi: 10.1210/clinem/dgab297. J Clin Endocrinol Metab. 2021. PMID: 33950216 Free PMC article.
References
-
- Anhê FF, Varin TV, Schertzer JD, et al. The gut microbiota as a mediator of metabolic benefits after bariatric surgery. Can J Diabetes. 2017;41:439–47. - PubMed
-
- Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: Primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94.
-
- Magro DO, Geloneze B, Delfini R, et al. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18:648–51. - PubMed
-
- Magro DO, Ueno M, Coelho-Neto JS, et al. Long-term weight loss outcomes after banded Roux-en-Y gastric bypass: a prospective 10-year follow-up study. Surg Obes Relat Dis. 2018;14:910–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials